Marsh & McLennan consensus picture on Tuesday, shares tracked against S&P 500 peers

Marsh & McLennan comes into Tuesday trading on the NYSE with a largely positive analyst stance and steady fundamentals, as investors compare the insurance broker’s valuation and growth profile with U.S. financial peers in the S&P 500.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 11:14.

Marsh & McLennan (US5717481023) starts Tuesday’s NYSE session with a broadly constructive Wall Street view, reflected in a majority of Buy and Overweight ratings on the stock. The company remains a heavyweight in the U.S. financials and insurance broker space alongside peers such as Aon and Willis Towers Watson.

What analysts are saying now

Across major houses, Marsh & McLennan is typically rated in the Buy to Hold range, with average 12?month price targets that imply only a moderate upside from recent trading levels according to MarketScreener’s consensus overview. Several brokers, including JPMorgan and Morgan Stanley, continue to highlight the group’s resilient fee-based revenue and strong cash generation.

Consensus earnings estimates compiled by MarketScreener point to low- to mid?single?digit revenue growth and solid margin stability over the next two years, which underpins the generally positive stance. The stock also offers a regular dividend, which many analysts see as well covered by operating cash flow.

How the stock screens against peers

On standard valuation metrics such as forward price-to-earnings and price-to-book ratios, Marsh & McLennan typically trades at a premium to the broader S&P 500 financials sector, but closer to the range seen for global insurance brokers like Aon and Willis Towers Watson. Analysts argue that this reflects the stability of its advisory and risk-management franchise and a diversified international client base.

Recent sector commentary from Reuters notes that insurance brokers have benefited from firm commercial pricing and a continued focus on risk and compliance spending among large corporates. This backdrop supports earnings visibility for Marsh & McLennan and its main competitors, even as investors stay attentive to U.S. interest-rate expectations and global macro indicators.

How Marsh & McLennan makes its money

Marsh & McLennan generates most of its revenue from risk and insurance services under the Marsh brand and from consulting activities at Mercer and Oliver Wyman. Clients range from large multinationals to mid-sized firms that use the group for insurance brokerage, benefits advice and strategy consulting.

Where the stock trades today

The Marsh & McLennan shares (US5717481023) most recently traded on the NYSE at around their recent consensus reference level in U.S. dollars, based on live quote data from major exchange portals on 2026-06-23, 11:00.

Key data on the Marsh & McLennan shares

• Company: Marsh & McLennan Companies, Inc.
• ISIN: US5717481023
• WKN: 857311
• Ticker: MMC
• Trading venue: NYSE
• Price (as of 2026-06-23, 11:00): latest indicative level in USD
• Market cap: large-cap range in USD (as of 2026-06-23)
• Sector / industry: Financials / Insurance brokers and consulting
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.